MedTrace Logo

Peripheral Oxygen Saturation (SpO2) Directed Oxygen Therapy

NCT02999932 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1706

Last updated 2023-07-11

No results posted yet for this study

Summary

Investigators hypothesized that a relative low SpO2 directed oxygen therapy would reduced the mortality in patients staying longer than 72 hours in ICUs.

Conditions

  • Critical Illness

Interventions

OTHER

SpO2 directed oxygen therapy

Oxygen therapy was administered to achieve targeted SpO2.

Sponsors & Collaborators

  • Wu Jieping Medical Foundation

    collaborator OTHER

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    lead OTHER

Principal Investigators

  • Shiying Yuan, MD · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2022-05-01
Completion
2022-05-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02999932 on ClinicalTrials.gov